Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain ; volume:9 ; number:1 ; day:10 ; month:2 ; year:2009 ; pages:1-14 ; date:12.2009
BMC neurology ; 9, Heft 1 (10.2.2009), 1-14, 12.2009
- Urheber
-
Quilici, Sibilia
- Beteiligte Personen und Organisationen
-
Chancellor, Jeremy
Löthgren, Mickael
Simon, Dominique
Said, Gerard
Le, Trong Kim
Garcia-Cebrian, Ana
Monz, Brigitta
SpringerLink (Online service)
- DOI
-
10.1186/1471-2377-9-6
- URN
-
urn:nbn:de:1111-2016030326751
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Quilici, Sibilia
- Chancellor, Jeremy
- Löthgren, Mickael
- Simon, Dominique
- Said, Gerard
- Le, Trong Kim
- Garcia-Cebrian, Ana
- Monz, Brigitta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
Pregabalin and gabapentin for chronic low back pain without radiculopathy: a systematic review
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
Pregabalin and gabapentin for chronic low back pain without radiculopathy: a systematic review
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
Retracted: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Retraction Note: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
Real-World Treatment of Post-herpetic Neuralgia with Gabapentin or Pregabalin
Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”